JAMP PHARMA
LIVE

Serial Number

79390054

Owner

JAMP PHARMA CORPORATION

Attorney

Brent E.. Routman

Filing Date

Sep 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

JAMP PHARMA Trademark

Serial Number: 79390054 • Registration: 7583174

JAMP PHARMA is a trademark filed by JAMP PHARMA CORPORATION on September 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

JAMP PHARMA CORPORATION (6 trademarks)

1310 rue Nobel

Entity Type: 03

Trademark Details

Filing Date

September 27, 2023

Registration Date

December 3, 2024

Published for Opposition

October 1, 2024

Goods & Services

Business management with relation to strategy, marketing, production, personnel and retail sale matters of pharmaceutical preparations, drugs and biosimilar biologic drugs for promoting optimal health of the human body, namely, prescription and non-prescription pharmaceutical preparations, vitamins and nutritional supplements

Pharmaceutical preparations, namely, prescription and non-prescription pharmaceutical preparations and drugs for the treatment of respiratory system diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, namely, brain diseases, spinal cord diseases and injuries, movement and seizure disorders, genitourinary diseases and disorders, namely, pelvic diseases, urological diseases and sexually transmitted diseases, gynecological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal system diseases and disorders, namely, connective tissue diseases, bone diseases, back pain, fractures, sprains, cartilage injuries, endocrine and metabolic diseases and disorders, namely, hyperlipidemia, hypercalcemia, diabetes, gout, anemia, cholestatic liver diseases, namely, primary biliary cirrhosis (PBC), skin diseases and disorders, namely, dermatitis and fungal diseases, ocular diseases and disorders, allergies, cold, cough, sinus diseases and disorders, hypertension, sexual diseases and disorders, prostate diseases and disorders, cancer, obesity, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, infectious diseases and disorders, namely, respiratory infections, eye infections, topical infections, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndrome, viral diseases and disorders, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids), parasitic diseases, namely, malaria, parasitic infections, namely, intestinal worms, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, dental and oral diseases, namely, mouth diseases, esophageal diseases and toothaches, motion sickness, carpal tunnel syndrome and pain, namely, headaches, migraines, back pain, pain from burns, neuropathic pain, chronic pain associated with osteoarthritis of the knee, transplant rejection, hyperfibrinolysis, hereditary angioedema, drug abuse and biosimilar biologic drugs for the treatment of inflammatory diseases and disorders, namely, inflammatory connective tissue diseases and inflammatory bowel diseases, skin diseases and disorders, namely, psoriasis and hidradenitis suppurativa, ocular diseases and disorders, namely, inflammation of the uvea or uveal tract; natural health product preparations, namely, dietary supplements, nutritional supplements and herbal supplements for general health and well-being, namely, food supplements containing natural plant extracts, natural algae, natural algae extracts and fungus extracts, vitamins, mineral supplements, amino acids, fatty acids, dietary fibre, probiotics dietary supplements, enzyme and protein supplements in powder, capsule, tablet and liquid form, all for maintaining brain health, for neuroprotection, for improving or preserving cognition, memory and brain function; vitamins and nutritional supplements, namely, vitamins and nutritional supplements in the form of calcium, electrolyte drinks, energy bars, energy drinks, juice drinks, lecithin, minerals, vitamins for pharmaceutical, medicinal and therapeutic use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 3, 2024 CNRT
ASSIGNED TO EXAMINER
May 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 22, 2024 REPR